'Medicinal products' presentation slideshows

World Bank Training Program on HIV/AIDS Drugs Training Module 4 Quality Assurance Ben K Botwe April 2005

World Bank Training Program on HIV/AIDS Drugs Training Module 4 Quality Assurance Ben K Botwe April 2005. Learning Objectives. Upon completion of this module, you will be able to. Explain the need for a systematic quality assurance process for pharmaceutical products

1.03k views • 82 slides

World Bank Training Program on HIV/AIDS Drugs Training Module 4 Quality Assurance Ben K Botwe April 2005

World Bank Training Program on HIV/AIDS Drugs Training Module 4 Quality Assurance Ben K Botwe April 2005. Learning Objectives. Upon completion of this module, you will be able to. Explain the need for a systematic quality assurance process for pharmaceutical products

978 views • 82 slides

Proactively Managing International and Foreign Corrupt Practices Act Compliance Risks - The Third Annual FDA Regulatory

Proactively Managing International and Foreign Corrupt Practices Act Compliance Risks - The Third Annual FDA Regulatory and Compliance Symposium. Gary F. Giampetruzzi, Pfizer Inc Assistant General Counsel and Deputy Compliance Officer Keith M. Korenchuk Covington & Burling LLP

824 views • 56 slides

GCP for Emergency Medicine

GCP for Emergency Medicine. GCP for Emergency Medicine. This presentation is intended for emergency physicians involved in recruiting patients to clinical trials and/or caring for patients who are in clinical trials

782 views • 56 slides

951 views • 54 slides

715 views • 54 slides

Legal Aspects of Prescribing

Legal Aspects of Prescribing. Steve Brown Director of Pharmacy, UBHT. Legal Aspects of Prescribing. You will be familiarised with the legislation governing the release and marketing of drugs You will learn about what is acceptable prescription writing and what is not

3.37k views • 53 slides

Documentation of bioequivalence

Documentation of bioequivalence. Drs. J. Welink. Workshop on WHO prequalification requirements for reproductive health medicines, Jakarta, October 2009. http://apps.who.int/prequal/. Bioequivalence. Bioequivalence: Two medicinal products are bioequivalents if

621 views • 41 slides

The Name Game : How the USPTO and Changing FDA Approval Processes Affect Protection of New Drug Names

The Name Game : How the USPTO and Changing FDA Approval Processes Affect Protection of New Drug Names. Lisa M. Tittemore, Esq. Keith E. Toms, Esq. Bromberg & Sunstein LLP November 5, 2008. Presentation Overview.

583 views • 34 slides

Regulatory and Scientific Issues of Biosimilars

Regulatory and Scientific Issues of Biosimilars . Duu-Gong Wu, Ph.D. Executive Director, PharmaNet Member, FDA Alumni Association DIA China, Beijing, China May 16-18, 2011. Disclosures.

1.01k views • 31 slides

495 views • 30 slides

471 views • 27 slides

548 views • 26 slides

Validation of Bone Allograft Processing: Reducing Risk of Disease Transmission via Conventional Agents While Maintaining

Validation of Bone Allograft Processing: Reducing Risk of Disease Transmission via Conventional Agents While Maintaining Graft Performance. TSE Advisory Committee Meeting June 26, 2002 Gaithersburg, MD. Richard Russo Osteotech, Inc . Validation of Bone Allograft Processing.

429 views • 23 slides

JRC Institute for Health and Consumer Protection http://ihcp.jrc.ec.europa.eu/ http://www.jrc.ec.europa.eu/

354 views • 20 slides

Accessing new drugs: A regulator's perspective

Accessing new drugs: A regulator's perspective . International Society of Paediatric Oncology 2012 congress. Presented by: Ralf Herold Scientific Administrator, Paediatric Medicines Section, Human Medicines Special Areas, Human Medicines Development and Evaluation. "Access to new drugs" .

412 views • 18 slides

Protecting Patients: Research Governance in Practice

Protecting Patients: Research Governance in Practice. Mental Incapacity & The EU Directive. Directive 2001/20/EC.

280 views • 14 slides

Governance of Veterinary Medicinal Products: Need to Leverage Resources

Governance of Veterinary Medicinal Products: Need to Leverage Resources. Merton V. Smith, Ph.D., J.D. Director International Programs Center for Veterinary Medicine U.S. Food and Drug Administration. Need for Oversight of Veterinary Medicine Registration and Use.

276 views • 11 slides

Trademark Class 10 | Medical Instrument Products

Trademark class 10 is necessarily defined for medical instrument products and supplies during registration of such products with a mark or brand name, is powered by TM Law Act India to keep safe and distinct the one

203 views • 10 slides

The Urinary System & Excretion

The Urinary System & Excretion. Detoxification of the Blood. The Urinary System. Remember!. The liver detoxifies the blood by removing poisonous substances and detoxifying them. the Deamination of amino acids produces ammonia, a poison, which is then converted to urea.

194 views • 8 slides